Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method
Year: 2018
Type: article
Institutions: Statens Serum Institut, University of Copenhagen, Rigshospitalet, National and Kapodistrian University of Athens, Erasmus MC, University General Hospital Attikon, Instituto de Salud Carlos III, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria Gregorio Marañón
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Cidara Therapeutics
OpenAlex ID: W2791773668
